Kupffer Cell Release of Platelet Activating Factor Drives Dose Limiting Toxicities of Nucleic Acid Nanocarriers (original) (raw)
Comparison of Polymeric siRNA Nanocarriers in a Murine LPS-Activated Macrophage Cell Line: Gene Silencing, Toxicity and Off-Target Gene Expression
Raymond Schiffelers
Pharmaceutical Research, 2012
View PDFchevron_right
Multifunctional nanosystems: growing sanguinity in siRNA therapy
Owais Mohammad
International Journal of Nanomedicine, 2014
View PDFchevron_right
Solid polymeric microparticles enhance the delivery of siRNA to macrophages in vivo
Robert Pierce
Nucleic Acids Research, 2009
View PDFchevron_right
Optimizing the Intracellular Delivery of Therapeutic Anti-inflammatory TNF-α siRNA to Activated Macrophages Using Lipidoid-Polymer Hybrid Nanoparticles
Camilla Foged
Frontiers in Bioengineering and Biotechnology, 2021
View PDFchevron_right
Lipopeptide nanoparticles for potent and selective siRNA delivery in rodents and nonhuman primates
Kevin Love
Proceedings of the National Academy of Sciences, 2014
View PDFchevron_right
Mechanistically Probing Lipid-siRNA Nanoparticle-associated Toxicities Identifies Jak Inhibitors Effective in Mitigating Multifaceted Toxic Responses
xianzhi mao, Paul Burke, Bruce Ng
Molecular Therapy, 2011
View PDFchevron_right
Mechanistic profiling of the release kinetics of siRNA from lipidoid-polymer hybrid nanoparticles in vitro and in vivo after pulmonary administration
Camilla Foged
Journal of Controlled Release, 2019
View PDFchevron_right
Engineering of Solid Dosage Forms of siRNA-Loaded Lipidoid–Polymer Hybrid Nanoparticles Using a Quality-by-Design Approach
Camilla Foged
Methods in Molecular Biology, 2021
View PDFchevron_right
The development of an in vitro assay to screen lipid based nanoparticles for siRNA delivery
leticia arrington
Journal of Controlled Release, 2014
View PDFchevron_right
Efficient intracellular delivery of siRNA with a safe multitargeted lipid-based nanoplatform
Ibane Abasolo
Nanomedicine, 2013
View PDFchevron_right
Quantitation of Physiological and Biochemical Barriers to siRNA Liver Delivery via Lipid Nanoparticle Platform
Jerome Hochman
Molecular Pharmaceutics, 2014
View PDFchevron_right
Degradable lipid nanoparticles with predictable in vivo siRNA delivery activity
Boris Klebanov
Nature Communications, 2014
View PDFchevron_right
Nanocapsule-mediated cytosolic siRNA delivery for anti-inflammatory treatment
Riddha Das
Journal of controlled release : official journal of the Controlled Release Society, 2018
View PDFchevron_right
Maximizing the Potency of siRNA Lipid Nanoparticles for Hepatic Gene Silencing In Vivo
Muthusamy Jayaraman
2012
View PDFchevron_right
Toxicity profiling of several common RNAi-based nanomedicines: a comparative study
Dan Peer
Drug delivery and translational research, 2014
View PDFchevron_right
Multifunctional polymeric nanoparticles for oral delivery of TNF-α siRNA to macrophages
Mansoor Amiji
Biomaterials, 2013
View PDFchevron_right
Influence of Cationic Lipid Composition on Gene Silencing Properties of Lipid Nanoparticle Formulations of siRNA in Antigen-Presenting Cells
Genc Basha, Pieter Cullis
Molecular Therapy, 2011
View PDFchevron_right
Lipid nanoparticle delivery systems for siRNA-based therapeutics
Theresa Allen
Drug delivery and translational research, 2014
View PDFchevron_right
Enhancing in vivo cell and tissue targeting by modulation of polymer nanoparticles and macrophage decoys
owen Richfield
Nature communications, 2024
View PDFchevron_right
Investigation of the Safety Profile of Polymeric Nanomedicines in Vitro via Assessment of Macrophage and Hepatocyte Responses
Leagh Powell
Heriot-Watt University, 2019
View PDFchevron_right
Evaluation of Efficacy, Biodistribution, and Inflammation for a Potent siRNA Nanoparticle: Effect of Dexamethasone Co-treatment
Paul Burke, Jessica Seitzer, Alan Sachs, Laura Sepp-lorenzino
Molecular Therapy, 2010
View PDFchevron_right
The Effect of Chemical Modification and Nanoparticle Formulation on Stability and Biodistribution of siRNA in Mice
Kenneth Howard
Molecular Therapy, 2009
View PDFchevron_right
siRNA nanoparticles: the future of RNAi therapeutics for oncology?
James Mixson
Nanomedicine, 2014
View PDFchevron_right
Evidence Supporting the Safety of Pegylated Diethylaminoethyl-Chitosan Polymer as a Nanovector for Gene Therapy Applications
Maicon Segalla Petronio
International Journal of Nanomedicine, 2020
View PDFchevron_right
Efficiency of siRNA delivery by lipid nanoparticles is limited by endocytic recycling
Kevin Love
Nature Biotechnology, 2013
View PDFchevron_right
Characterization and comparison of two novel nanosystems associated with siRNA for cellular therapy
Emilie André
International journal of pharmaceutics, 2016
View PDFchevron_right
Development of a Combined Lipid-Based Nanoparticle Formulation for Enhanced siRNA Delivery to Vascular Endothelial Cells
Dongdong Bi
Pharmaceutics
View PDFchevron_right
Small molecule ligands for enhanced intracellular delivery of lipid nanoparticle formulations of siRNA
marco ciufolini
Nanomedicine: Nanotechnology, Biology and Medicine, 2013
View PDFchevron_right
Effect of the nanoformulation of siRNA-lipid assemblies on their cellular uptake and immune stimulation
Shinji Takeoka
International journal of nanomedicine, 2017
View PDFchevron_right